Versor Investments’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Versor Investments’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-113,905	Closed	-$2.16M	–	372
2019 Q1	$2.16M	Buy	+113,905	New	+$1.85M	0.21%	50

Other funds holding OSIR

FGAM

Financial Gravity Asset Management Lakeway, Texas $562M AUM

Versor Investments's OSIR Position: Q2 2019 in Review

Versor Investments sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 113,905 shares — an estimated $2.16M sold.

Versor Investments first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $2.16M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

Versor Investments reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
Versor Investments sold 113,905 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $2.16M.
Versor Investments first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
Versor Investments's Osiris Therapeutics, Inc. Common Stock position peaked at $2.16M in Q1 2019.
1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Versor Investments's 13F filing for Q2 2019, filed 29 Jul 2019.